Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Appointed director
Quarterly results
Consulting agrmnt
Employment agrmnt
Asset disposition
REPROS THERAPEUTICS INC. (RPRX)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
04/21/2021
GN
Royalty Pharma to Announce First-Quarter 2021 Financial Results on May 11, 2021
04/21/2021
GN
Royalty Pharma Announces Strategic Alliance With MSCI to Launch Life Sciences Indexes
04/15/2021
GN
Royalty Pharma Declares Second-Quarter 2021 Dividend
04/08/2021
GN
Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
02/17/2021
GN
Royalty Pharma Reports Q4 2020 and Full-Year Results
01/22/2021
GN
Royalty Pharma to Announce Fourth-Quarter 2020 Financial Results on February 17, 2021
01/08/2021
GN
Royalty Pharma Announces 13% Dividend Increase
12/22/2020
GN
Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities
12/21/2020
GN
Royalty Pharma Announces Expansion of Leadership Team
12/07/2020
GN
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
12/07/2020
GN
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
11/10/2020
GN
Royalty Pharma Reports Third Quarter 2020 Results
11/02/2020
GN
Royalty Pharma Acquires Additional Royalty Interest From the Cystic Fibrosis Foundation
10/20/2020
GN
Royalty Pharma Announces Closing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
10/15/2020
GN
Royalty Pharma Announces Pricing of Secondary Offering of Class A Ordinary Shares by Selling Shareholders
10/15/2020
GN
Royalty Pharma Declares Fourth-Quarter 2020 Dividend
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy